t
Sapna Shah, a Director of BioPharma Credit PLC, purchased 42,500 Ordinary Shares of $0.01 each in the company on March 25, 2026. The shares were acquired on the London Stock Exchange at a price of $0.94 per share, for a total aggregated price of $39,950.00 (£29,902.27).
| Date | 25 Mar 2026 |
| Time | 18:23:19 |
| Category | Director/PDMR dealings |
| ID | 1585Y |
BIOPHARMA CREDIT PLC
Notification of Transactions by
Persons Discharging Managerial Responsibilities and
Persons Closely Associated with them
|
1. |
Details of person discharging managerial responsibilities/person closely associated with them |
||||||
|
a) |
Name |
Sapna Shah |
|||||
|
2. |
Reason for the notification |
||||||
|
a) |
Position / status |
Director of BioPharma Credit PLC |
|||||
|
b) |
Initial notification / amendment |
Initial notification |
|||||
|
3. |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
||||||
|
a) |
Name |
BioPharma Credit PLC |
|||||
|
b) |
LEI |
213800AV55PYXAS7SY24 |
|||||
|
4. |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
||||||
|
a) |
Description of the financial instrument
Identification Code |
Ordinary Shares of $0.01 each
GB00BDGKMY29 |
|||||
|
b) |
Nature of the transaction |
Purchase of Shares |
|||||
|
c) |
Price(s) and volume(s) |
|
|||||
|
d) |
Aggregated information - Aggregated volume
- Price |
42,500
$39, 950.00 (Converted to GBP @ 1.336019 = £29,902.27) |
|||||
|
e) |
Date of the transaction |
25.03.2026 |
|||||
|
f) |
Place of the transaction |
London Stock Exchange (XLON) |
|||||